{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:05:55Z","timestamp":1784549155112,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.esmoop.2026.107731","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:30:19Z","timestamp":1781292619000},"page":"107731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term outcomes and treatment response in early-stage invasive lobular carcinoma: insights from a nationwide population-based study"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7864-3637","authenticated-orcid":false,"given":"G.","family":"Nader-Marta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ameye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7214-4818","authenticated-orcid":false,"given":"D.","family":"Martins-Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4636-7636","authenticated-orcid":false,"given":"N.","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Verbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aftimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Buisseret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Paesmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7167-3868","authenticated-orcid":false,"given":"C.","family":"Molinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5430-8957","authenticated-orcid":false,"given":"E.L.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-5296","authenticated-orcid":false,"given":"M.","family":"Lambertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Van Baelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Desmedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Piccart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"de Azambuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.esmoop.2026.107731_bib1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.annonc.2022.05.006","article-title":"Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer","volume":"33","author":"Van Baelen","year":"2022","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.107731_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.esmoop.2026.107731_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.107731_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10549-023-07044-5","article-title":"Clinical characteristics and treatment outcomes of invasive ductal and lobular carcinoma: analyses of 54,832 Taiwan cancer registry index cases","volume":"201","author":"Chen","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.esmoop.2026.107731_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13058-023-01745-x","article-title":"Histologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancer","volume":"25","author":"G\u00f6ker","year":"2023","journal-title":"Breast Cancer Res"},{"issue":"9","key":"10.1016\/j.esmoop.2026.107731_bib6","article-title":"Invasive lobular carcinoma of the breast: a special histological type compared with invasive ductal carcinoma","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.esmoop.2026.107731_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262709","article-title":"Survival analysis in patients with invasive lobular cancer and invasive ductal cancer according to hormone receptor expression status in the Korean population","volume":"17","author":"Kwon","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.esmoop.2026.107731_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.590643","article-title":"Comparison of overall survival between invasive lobular breast carcinoma and invasive ductal breast carcinoma: a propensity score matching study based on SEER database","volume":"10","author":"Yang","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.107731_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jnci\/djae188","article-title":"Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trials","volume":"117","author":"Foldi","year":"2025","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"10.1016\/j.esmoop.2026.107731_bib10","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1200\/JCO.2007.14.9336","article-title":"Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials","volume":"26","author":"Pestalozzi","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.107731_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13058-023-01750-0","article-title":"Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials","volume":"25","author":"Dayan","year":"2023","journal-title":"Breast Cancer Res"},{"issue":"4","key":"10.1016\/j.esmoop.2026.107731_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.breast.2014.01.007","article-title":"Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER data","volume":"23","author":"Brouckaert","year":"2014","journal-title":"Breast"},{"key":"10.1016\/j.esmoop.2026.107731_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.breast.2021.11.017","article-title":"Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery\u2013a systematic review and meta-analysis","volume":"61","author":"O\u2019Connor","year":"2022","journal-title":"Breast"},{"issue":"16","key":"10.1016\/j.esmoop.2026.107731_bib14","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1200\/JCO.2012.46.2440","article-title":"Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: results from the HERA trial","volume":"31","author":"Metzger-Filho","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.107731_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41523-024-00627-5","article-title":"Reporting on invasive lobular breast cancer in clinical trials: a systematic review","volume":"10","author":"Van Baelen","year":"2024","journal-title":"NPJ Breast Cancer"},{"issue":"12","key":"10.1016\/j.esmoop.2026.107731_bib18","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.annonc.2023.10.001","article-title":"ESMO Guidance for Reporting Oncology real-World evidence (GROW)","volume":"34","author":"Castelo-Branco","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2026.107731_bib19","series-title":"International Classification of Diseases for Oncology (ICD-O)","year":"2013"},{"issue":"11","key":"10.1016\/j.esmoop.2026.107731_bib20","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/jnci\/djac157","article-title":"Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer","volume":"114","author":"Oesterreich","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"10.1016\/j.esmoop.2026.107731_bib21","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1002\/cncr.33104","article-title":"Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer","volume":"126","author":"Christgen","year":"2020","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.esmoop.2026.107731_bib22","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1002\/cncr.30699","article-title":"Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast","volume":"123","author":"Marmor","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.esmoop.2026.107731_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102205","article-title":"Benefit of adjuvant chemotherapy in patients with lobular breast cancer: a systematic review of the literature and metanalysis","volume":"97","author":"Trapani","year":"2021","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"10.1016\/j.esmoop.2026.107731_bib24","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1245\/s10434-020-08895-8","article-title":"Population trends in lobular carcinoma of the breast: the Ontario experience","volume":"27","author":"Findlay-Shirras","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.107731_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/1055-9965.EPI-24-1250","article-title":"Treatment and survival differences between patients with invasive lobular carcinoma versus invasive ductal carcinoma of the breast","volume":"34","author":"Anampa","year":"2025","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.esmoop.2026.107731_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13058-020-01384-6","article-title":"Invasive lobular carcinoma of the breast: the increasing importance of this special subtype","volume":"23","author":"McCart Reed","year":"2021","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.esmoop.2026.107731_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13058-015-0605-0","article-title":"Lobular breast cancer series: imaging","volume":"17","author":"Johnson","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"11","key":"10.1016\/j.esmoop.2026.107731_bib28","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.annonc.2025.07.008","article-title":"Clinical challenges and proposed solutions for patients with invasive lobular breast cancer","volume":"36","author":"Van Baelen","year":"2025","journal-title":"Ann Oncol"},{"issue":"10503","key":"10.1016\/j.esmoop.2026.107731_bib29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(25)01013-X","volume":"406","year":"2025","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.esmoop.2026.107731_bib30","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2967\/jnumed.115.161455","article-title":"Comparison of 18F-FDG PET\/CT for systemic staging of newly diagnosed invasive lobular carcinoma versus invasive ductal carcinoma","volume":"56","author":"Hogan","year":"2015","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.esmoop.2026.107731_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.23435","article-title":"ER-targeted PET for initial staging and suspected recurrence in ER-positive breast cancer","volume":"7","author":"Ulaner","year":"2024","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.esmoop.2026.107731_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-014-2861-6","article-title":"Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma","volume":"144","author":"Loibl","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.esmoop.2026.107731_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.breast.2021.06.011","article-title":"Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations","volume":"59","author":"Conforti","year":"2021","journal-title":"Breast"},{"issue":"9","key":"10.1016\/j.esmoop.2026.107731_bib34","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.esmoop.2026.107731_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10549-022-06813-y","article-title":"Do non-classic invasive lobular carcinomas derive a benefit from neoadjuvant chemotherapy?","volume":"197","author":"Mamtani","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"9_suppl","key":"10.1016\/j.esmoop.2026.107731_bib36","first-page":"PO2","article-title":"Abstract PO2-07-09: Early stage invasive lobular breast cancer is underestimated on conventional imaging including MRI","volume":"84","author":"Van Herck","year":"2024","journal-title":"Cancer Res"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292601673X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292601673X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:21:47Z","timestamp":1784546507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S205970292601673X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S205970292601673X"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.107731","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes and treatment response in early-stage invasive lobular carcinoma: insights from a nationwide population-based study","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.107731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"107731"}}